ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,350,000 | -14.8% | 129,864 | +76.6% | 0.01% | -18.2% |
Q4 2020 | $3,931,000 | +30.3% | 73,534 | +0.6% | 0.01% | 0.0% |
Q3 2020 | $3,016,000 | -10.8% | 73,119 | +4.8% | 0.01% | -15.4% |
Q2 2020 | $3,382,000 | -18.0% | 69,770 | -28.6% | 0.01% | -43.5% |
Q1 2020 | $4,126,000 | +38.9% | 97,661 | +40.7% | 0.02% | +43.8% |
Q4 2019 | $2,970,000 | +551.3% | 69,426 | +447.7% | 0.02% | +433.3% |
Q3 2019 | $456,000 | – | 12,676 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |